Skip to main content
Equibles
SANA logo

SANA · Sana Biotechnology, Inc. · Held by Funds

Track SANA — free

Use SANA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SANA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.41 +0.11 (+4.77%)
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Management has determined that our present capital resources may not be sufficient to fund our planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to our ability to continue as a going concern.”
View the 10-Q filed Aug 10, 2026
Market Cap
$688.53M
Shares
299.36M
Volume · Oct 20 3.48M Avg daily vol (3M) 3.2M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of SANA by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 11.18% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.00% 5,984,677
Index ETFs 9.18% 27,480,677
Active ETFs 0.05% 142,266
Active funds 6.61% 19,773,951
Unclassified 0.00% 0
All registered funds 17.83% 53,381,571
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding SANA

151 fund positions
Fund Balance Value % of Fund Open
Fidelity Growth Company Fund 10,508,590 $34,678,347 0.04%
State Street(R) SPDR(R) S&P(R) Biotech ETF 7,077,517 $24,700,534 0.23%
VANGUARD TOTAL STOCK MARKET INDEX FUND 6,251,644 $21,818,238 0.00%
iShares Russell 2000 ETF 4,807,959 $16,779,777 0.02%
Fidelity Growth Company K6 Fund 3,106,086 $10,250,084 0.04%
Fidelity Series Growth Company Fund 2,857,700 $9,430,410 0.04%
VANGUARD EXTENDED MARKET INDEX FUND 1,920,775 $6,703,505 0.01%
Fidelity Small Cap Index Fund 2,008,443 $6,286,427 0.02%
iShares Russell 2000 Growth ETF 1,680,858 $5,866,194 0.04%
iShares Biotechnology ETF 1,276,572 $4,455,236 0.05%
Select Biotechnology Portfolio 1,263,152 $4,168,402 0.08%
VANGUARD RUSSELL 2000 INDEX FUND 863,772 $2,850,448 0.02%
Fidelity Extended Market Index Fund 843,865 $2,784,755 0.01%
Schwab U.S. Small-Cap ETF 770,926 $2,544,056 0.01%
VANGUARD HEALTH CARE INDEX FUND 520,072 $1,716,238 0.01%
Schwab Small-Cap Index Fund 446,761 $1,398,362 0.02%
iShares U.S. Small-Cap Equity Factor ETF 422,400 $1,322,112 0.03%
Invesco RAFI US 1500 Small-Mid ETF 387,056 $1,211,485 0.04%
Master Small Cap Index Series 343,323 $1,198,197 0.02%
Fidelity Total Market Index Fund 296,382 $978,061 0.00%
iShares Core S&P Total U.S. Stock Market ETF 254,240 $887,298 0.00%
Fidelity Series Total Market Index Fund 247,233 $815,869 0.00%
Nuveen Small Cap Blend Index Fund 243,516 $762,205 0.02%
Direxion Daily S&P Biotech Bull 3X Shares 240,493 $752,743 0.15%
EQ/2000 Managed Volatility Portfolio 200,451 $699,574 0.02%
Goldman Sachs Small Cap Equity Insights Fund 223,347 $699,076 0.07%
BlackRock Advantage Small Cap Core Fund 205,964 $679,681 0.01%
Fidelity Small Cap Growth Index Fund 172,119 $600,695 0.04%
IQ U.S. Small Cap ETF 100,150 $549,824 0.31%
Fidelity Nasdaq Composite Index Fund 166,155 $548,312 0.00%
Optimize Strategy Index ETF 140,217 $489,357 0.17%
PACE Small/Medium Co Growth Equity Investments 152,878 $478,508 0.19%
LVIP State Street Small-Cap Index Fund 131,900 $460,331 0.02%
Schwab U.S. Broad Market ETF 125,731 $414,912 0.00%
VANGUARD RUSSELL 2000 VALUE INDEX FUND 119,630 $394,779 0.03%
Virtus Biotech Clinical Trials Etf 115,976 $363,005 0.78%
EQ/Small Company Index Portfolio 100,550 $350,920 0.02%
Dimensional U.S. Small Cap ETF 110,952 $347,280 0.00%
Small Cap Index Fund 94,975 $331,463 0.02%
VANGUARD BALANCED INDEX FUND 94,454 $329,644 0.00%
SMALL COMPANY GROWTH PORTFOLIO 93,437 $326,095 0.02%
Nuveen Equity Index Fund 104,083 $325,780 0.00%
NVIT Multi-Manager Small Company Fund 89,400 $312,006 0.07%
U.S. SMALL CAP PORTFOLIO 98,990 $309,839 0.00%
Fidelity Nasdaq Composite Index ETF 92,682 $305,851 0.00%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND 87,444 $305,180 0.00%
Fidelity ZERO Total Market Index Fund 91,087 $285,102 0.00%
NVIT Small Cap Value Fund 80,800 $281,992 0.13%
Global X Russell 2000 ETF 87,720 $274,564 0.02%
Goldman Sachs Small Cap Growth Insights Fund 84,863 $265,621 0.08%
Showing 1–50 of 151 positions
Key facts CIK 1770121 CUSIP 799566104 13F (30d) 14 filings 14 filers Visit website Investor relations